Lemonex Inc.

13 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Mar 2035

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jan 18, 2027
The maintenance fee for RNA and nucleic acid carrier including the same (US 11,701,378) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
3 fees due Apr 10 to 24, 2027 · next Apr 10

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 11,786,469	Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasome In force Term ends Mar 31, 2035 · From the USPTO record	In force	Term ends Mar 31, 2035	From the USPTO record
US 10,809,196	Quencher containing water soluble polymer-conjugated nanomaterial and use thereof In force Term ends May 27, 2037 · From the USPTO record	In force	Term ends May 27, 2037	From the USPTO record
US 11,779,582	Composition for preventing or treating metastatic ovarian cancer, endometrial cancer or breast cancer In force Term ends Feb 1, 2038 · From the USPTO record	In force	Term ends Feb 1, 2038	From the USPTO record
US 12,138,346	Physiologically Active Substance Carrier In force Ends no later than Feb 6, 2038 · Low confidence	In force	Ends no later than Feb 6, 2038	Low confidence
US 11,129,796	Physiologically Active Substance Carrier In force Term ends Apr 28, 2038 · High confidence	In force	Term ends Apr 28, 2038	High confidence
US 11,530,132	Composition Comprising Porous Silica Particles Carrying a Cell Fate Modulating Factor In force Term ends Apr 28, 2038 · High confidence	In force	Term ends Apr 28, 2038	High confidence
US 11,793,757	Physiologically Active Substance Carrier In force Term ends Apr 28, 2038 · Medium confidence	In force	Term ends Apr 28, 2038	Medium confidence
US 12,076,336	Pharmaceutical composition for preventing or treating liver cancer In force Term ends Jul 30, 2038 · From the USPTO record	In force	Term ends Jul 30, 2038	From the USPTO record
US 11,633,447	Pharmaceutical composition and functional health food for preventing or treating macular degeneration In force Term ends Feb 7, 2040 · From the USPTO record	In force	Term ends Feb 7, 2040	From the USPTO record
US 11,701,378	RNA and nucleic acid carrier including the same In force Term ends Jul 5, 2041 · From the USPTO record	In force	Term ends Jul 5, 2041	From the USPTO record

10 of 13 patents shown.

Pro members see all 13.

Pro members: see all 13 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 8 no status recorded

List them